Quintiles IMS explores sale of contract sales business -sources

June 21 (Reuters) - Clinical researcher and pharmaceutical market data specialist Quintiles IMS Holdings Inc is exploring a sale of its contract sales business that could value it at as much as $1 billion, according to people familiar with the matter.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.